Avadel Pharmaceuticals plc (AVDL)
NASDAQ: AVDL · Real-Time Price · USD
11.66
0.00 (0.00%)
Nov 22, 2024, 4:00 PM EST - Market closed
Avadel Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 22, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Debt / Equity Ratio | 0.51 | 0.41 | -6.20 | 1.85 | 0.80 | -4.46 | |
| Asset Turnover | 0.76 | 0.19 | - | - | 0.10 | 0.35 | |
| Inventory Turnover | 1.04 | - | - | - | - | 2.91 | |
| Quick Ratio | 2.41 | 3.22 | 1.77 | 8.99 | 17.30 | 2.12 | |
| Current Ratio | 2.97 | 3.64 | 1.81 | 9.17 | 17.44 | 2.29 | |
| Return on Equity (ROE) | -78.54% | -481.35% | -481.49% | -64.30% | 10.56% | - | |
| Return on Assets (ROA) | -22.14% | -57.92% | -31.32% | -19.14% | -9.90% | -6.15% | |
| Return on Capital (ROIC) | -28.75% | -73.72% | -35.73% | -20.73% | -11.64% | -9.58% | |
| Buyback Yield / Dilution | -27.63% | -33.41% | -2.66% | -6.54% | -46.89% | -0.21% | |
| Total Shareholder Return | -27.63% | -33.41% | -2.66% | -6.54% | -46.89% | -0.21% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.